Medicines

Mandaviya arrived at Delhi's Vijay Chowk to take part in the walkathon on the occasion of the World Health Day

Co aiming to hit the markets this year to raise over Rs 4,000 crore

Prices of 900 formulations are expected to increase to reflect annual change in WPI

The CDSCO has issued show cause notices to 31 firms based on representations raising concerns over the sale of drugs online or through other electronic platforms in contravention to the provisions of the Drugs and Cosmetics Act, 1940, the government informed the Lok Sabha on Friday. Cases concerning the quality of drugs, when reported, was is taken up with the State Licensing Authority (SLA) concerned for necessary action under the provisions of the Drugs and Cosmetics Act, Minister of State for Health Bharati Pravin Pawar said in a written reply. The SLAs are empowered to take action on violation of any conditions of such licenses, including prosecution in an appropriate court of law. She also told the Lower House of Parliament that as informed by Central Drugs Standard Control Organisation (CDSCO), various representations are received raising concerns regarding the sale of drugs through online or other electronic platforms in contravention to the provisions of the Drugs and ...

Days after the demise of 66-year-old veteran actor, Satish Kaushik, a crime team of Delhi's South-West district police visited the farmhouse, where the deceased actor was staying, sources said

Union Health Minister Mansukh Mandaviya on Friday said that India sent medicines to 150 countries during covid crisis without increasing the price and compromising on the quality of the medicines

The Punjab Assembly on Thursday passed a resolution recommending the state government to cap the profit margins on medicines charged by private players. Politicians from both sides of the aisle recommended the state to take up with the Centre the "looting" of people by exorbitantly priced medicines. Raising the matter in the ongoing budget session of the Punjab Vidhan Sabha, some members suggested capping of profit margins on medicines, while many others, mainly from opposition, demanded strengthening of the government health sector in the state. As he moved the resolution in the House, AAP MLA from Chamkaur Sahib, Dr Charanjit Singh, said exorbitant rates of medicines was robbing people of their money forcing many people to sell their properties to afford costly medicines. Not only chemists, but several known private hospitals are selling medicines at higher prices than MRP, said Singh, adding that the matter was not peculiar to Punjab, but afflicts the whole country. He said ..

The official added that the passenger has committed offence punishable under Sections 132 and 135 of the Customs Act

The company Marion Biotech had supplied the cough syrups that reportedly caused the deaths of Children in Uzbekistan

The Maharashtra government told the state Legislative Assembly on Friday that the licenses of six manufacturers of cough syrups in the state have been suspended for not following the rules. Food and Drugs Administration Minister Sanjay Rathod made the statement while replying to a calling attention notice by Ashish Shelar (BJP) and others. Recently, a cough syrup made by a Noida-based firm was alleged to have caused the death of 18 children in Uzbekistan. Noida police on Friday said they had arrested three employees of the firm. Rathod said that the Maharashtra government had initiated inquiry against 84 out of 108 manufacturers of cough syrups in the state. Four of them were directed to stop production while the licences of six companies were suspended, he said. As many as 17 firms were served show-cause notices for violation of rules, the minister added. Shelar referred to the deaths of 66 children in Gambia allegedly because of cough syrups imported from India. But the ...

Inadequate knowledge and prolonged and irrational use of medicines can be fatal for the health of kidneys, experts said on Friday. As the number of people with kidney ailments rise steadily, experts said if timely attention is not given to the matter, it might assume an epidemic proportion. Experts from various states participated virtually at the 'Kidney Manthan 2.0' organised by AIMIL Pharmaceuticals. Dr Prabhu S, an internal medicine specialist from Bengaluru, spoke about drug induced renal disorders and their management. At the webinar, he said people usually keep on consuming medicines over an extended period of time without consulting doctors and without realising the threat it poses to them. Dr Sathya N Dornala, senior doctor from Swami Vivekananda Ayurvedic Hospital, New Delhi, dwelled in detail about several medicines that should not be taken over-the-counter (OTC) and added that patients should be careful while taking drugs as these can damage the kidneys. At the same

The Global Center for Traditional Medicine of World Health Organisation (WHO-GCTM) will help member countries take measures in their respective countries to strengthen education and practices of traditional medicine, Union Minister Sarbnanda Sonowal said. Sonowal, the union minister of Ayush, inaugurating the first B2B Global Conference and Expo on Traditional Medicine under Shanghai Cooperation Organisation (SCO) here, said India has made the best use of available natural resources through Ayurveda and other traditional systems of medicine to provide healthcare to its people. India is focused on making best use of traditional medicine to achieve the goal of universal health coverage, he said. It is with this goal that the country has supported the establishment of the Global Center for Traditional Medicine of World Health Organisation (WHO-GCTM) at Jamnagar in Gujarat, Sonowal said. ''It will help member countries in taking measures in their respective countries to strengthen ...

"Within the federal democratic structure of the country, both the Centre and states are required to work together in harmony and synergy to ensure that we establish robust regulatory systems," he said

Ranitidine has been in existence for over four decades and has been on the WHO list of essential medicines for several years

The Punjab government will soon write a letter to the Centre to bring the prices of non-scheduled medicines under control, according to a decision taken at a meeting convened by Vidhan Sabha Speaker Kultar Singh Sandhwan on Tuesday. The move is aimed at stopping the fleecing of the public due to the exorbitant rates of medicines, an official statement said. Sandhwan said that drug price fixing is the central government subject and "licensed loot of patients has been legalized in the current system". "Finding an immediate solution to this very sensitive issue of the people's lives is the need of the hour. The Union government should immediately look into this matter and amend the law so that patients' loot could be stopped at once," he said, as per the statement. During the meeting, MLAs, health experts, doctors and representatives of various NGOs spoke about the actual rate and maximum retail prices of the medicines, showing the difference in prices of up to 90 per cent along with

Zydus Lifesciences on Monday said it has received approval from the US health regulator to market generic medicines in the American market. The company has received approval from the US Food and Drug Administration (USFDA) to market Gabapentin tablets which are indicated for the management of postherpetic neuralgia (PHN). As per IQVIA MAT data, the medication had annual sales of USD 90 million in the US. The company said it also has received approval from the US health regulator for diabetes drug Canagliflozin and Metformin Hydrochloride tablets. As per IQVIA MAT data, Canagliflozin and Metformin Hydrochloride tablets had annual sales of USD 49.4 million in the US. Shares of the company on Monday ended 1.36 per cent down at Rs 464.15 apiece on the BSE.

Eight more places in West Bengal have been earmarked for the launch of drone delivery of medicines in the coming days

Gives firms two days to respond to allegations that they flouted rules

Sun Pharmaceutical Industries on Friday said its subsidiary has received approval from the US health regulator to market a generic medication used in the treatment of multiple myeloma. The company has received final approval from the US Food and Drug Administration (USFDA) for the generic lenalidomide capsules in multiple strengths, Sun Pharma said in a statement. In June 2021, Sun Pharma entered into a settlement with Celgene Corporation (Celgene) to resolve the patent litigation regarding its generic lenalidomide capsules. Under the terms of this settlement, Celgene granted Sun Pharma a license to patents required to manufacture and sell certain limited quantities of generic lenalidomide capsules in the US, beginning sometime after March 2022. In addition, the license allows Sun Pharma to manufacture and sell an unlimited quantity of generic lenalidomide capsules in the US beginning January 31, 2026. Shares of Sun Pharma were trading 0.48 per cent down at Rs 1,002 apiece on the

In the wake of fatalities among children linked to cough syrups and medicines made by manufacturers based in India and Indonesia, the WHO has issued an "urgent call to action to countries to detect and respond to incidents of falsified medical products and protect children from contaminated medicines. The World Health Organisation (WHO) said that over the past four months, countries reported several incidents of over-the-counter cough syrups for children with confirmed or suspected contamination with high levels of diethylene glycol (DEG) and ethylene glycol (EG). The cases are from at least seven countries, associated with more than 300 fatalities in three of these countries, with most young children under the age of five. The WHO said the contaminants are toxic chemicals used as industrial solvents and antifreeze agents that can be fatal even in small amounts, and should never be found in medicines. WHO is releasing an urgent call to action to countries to prevent, detect and ...